Article
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.
AIDS (London, England) - 31 Jul 2012
Calcagno Andrea, Yilmaz Aylin, Cusato Jessica, Simiele Marco, Bertucci Roberto, Siccardi Marco, Marinaro Letizia, D'Avolio Antonio, Di Perri Giovanni, Bonora Stefano
Abstract excerpt
OBJECTIVES: To compare cerebrospinal fluid (CSF) darunavir and ritonavir concentrations in patients receiving darunavir/ritonavir 800/100 mg once daily or 600/100 mg twice daily. To determine the influence of single-nucleotide polymorphisms in the genes encoding for blood-brain barrier transporters (ABCB1 3435 C>T, ABCB1 1236 C>T, ABCB1 2677 G>T, SLCO1A2 38 A>G, SLCO1A2 516 A>C, ABCC2 -24 G>A) on darunavir and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
